Medical Microinstruments
Jacksonville, Florida, United States · Biotechnology, Health Care, Medical
Medical Microinstruments (MMI) specializes in developing the Symani Surgical System, which enables surgeons to mimic human hand movements at a microscale and broaden treatment options for soft tissue and open surgical procedures.
Key facts
- Headquarters
- Jacksonville, Florida, United States
- Employees
- 51
- Industries
- Biotechnology, Health Care, Medical
- Status
- Private
- Website
- mmimicro.com
- Company page
Recent activity at Medical Microinstruments
- : Medical Microinstruments, Inc. raises $125 million in Series D financing, led by BioStar Capital, to accelerate the commercial growth of the Symani Surgical System worldwide.
- : USF and TGH partner with robotics company to bring life-saving surgical technology to Tampa Bay
- : MMI Raises $110 Million in Series C Financing
- : Medical Microinstruments Secures $75M To Advance Robotic Microsurgery
Medical Microinstruments funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2026 | Series D | $125.0M |
| Feb 2024 | Series C | $110.0M |
| Jul 2022 | Funding Round | $75.0M |
Leadership
- Caleb Moore, Chief Financial Officer
- Mark Toland, Chief Executive Officer
Verified email and direct lines for Medical Microinstruments’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Medical Microinstruments in the news
- MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients - BioSpace (Nov 06, 2025)
- MMI Completes World’s First Robotic Preclinical Study in Neurosurgery with Symani® Surgical System - Business Wire (Aug 01, 2024)
- MMI Receives FDA Approval to Advance to Phase II of Patient - GlobeNewswire (Jul 30, 2026)
- Medical Microinstruments S.p.A. Announces €20M in Series A Funding to Advance Its Robotic Platform for Microsurgery - PR Newswire (Apr 18, 2018)
- MMI’s Symani® Surgical System Named a TIME Best Invention of 2024 - Business Wire (Oct 30, 2024)
- MMI’s Symani® System Redefines Robotic Microsurgery Again - GlobeNewswire (Jul 10, 2025)
- MMI’s Symani Surgical System Treats First Alzheimer’s Patient in Groundbreaking REMIND Study - GlobeNewswire (May 04, 2026)
- MMI Completes First Symani® Clinical Cases in the U.S. Following FDA Commercial Authorization - Business Wire (May 01, 2024)
Companies similar to Medical Microinstruments
- Odysight.ai · Biotechnology, Health Care, Medical, Medical Device, Software
- Cercare Medical · Biotechnology, Health Care, Medical, Medical Device, Software
- Surgimate · Biotechnology, Health Care, Medical, Medical Device, Software
- RADNOSTIX · Biotechnology, Health Care, Medical, Medical Device, Software
- Ligence · Biotechnology, Health Care, Medical, Medical Device, Software
About Medical Microinstruments: questions and answers
What does Medical Microinstruments do?
Medical Microinstruments (MMI) specializes in developing the Symani Surgical System, which enables surgeons to mimic human hand movements at a microscale and broaden treatment options for soft tissue and open surgical procedures.
Where is Medical Microinstruments headquartered?
Medical Microinstruments is headquartered in Jacksonville, Florida, United States.
How many employees does Medical Microinstruments have?
Medical Microinstruments has about 51 employees.
Has Medical Microinstruments raised funding?
Yes. Fundz has recorded 3 funding events for Medical Microinstruments. The most recent, Series D of $125.0M, was in Oct 2026.
Who leads Medical Microinstruments?
Mark Toland is a Chief Executive Officer at Medical Microinstruments.
What is the latest news on Medical Microinstruments?
On Oct 08, 2026, Medical Microinstruments, Inc. raises $125 million in Series D financing, led by BioStar Capital, to accelerate the commercial growth of the Symani Surgical System worldwide.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy